Clinical Trials Browser

Breast Neoplasms

NCT05191940 2026-03-20

LAPC

Phase NA Recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06492122 2026-01-29

ProTACT

Phase 1 Recruiting

50 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04968548 2025-11-04

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Active not recruiting

5,000 enrolled

Thoracic

Lung Neoplasms

NCT06889844 2025-10-01

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

Recruiting

250 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04951154 2025-08-19

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Completed

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06605404 2025-08-14

Pan-tumor MRD Study

Recruiting

1,350 enrolled

DermatologicGastrointestinalThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma

NCT06122077 2025-08-05

PROACT-LUNG

Recruiting

20,000 enrolled

Thoracic

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

NCT05854368 2025-05-16

PREGASIGN#1

Phase NA Recruiting

2,500 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04875871 2025-05-11

PARTICLE-PATHY

Phase NA Terminated

13 enrolled

Tumor-Agnostic

Neoplasms

NCT05962905 2025-05-09

INCATH

Completed

110 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

REMERGE

LAPC

ProTACT

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Pan-tumor MRD Study

PROACT-LUNG

PREGASIGN#1

PARTICLE-PATHY

INCATH